source
- From confidence to capital: Positioning biotech for the next growth cycleHow can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.
- ‘This could be a large market’: Novo Holdings-backed Claris secures $118M for corneal disease drugA new biotech has come into view with a $118 million series B and a vision for making the front of the eye front-of-mind.